RELATED-PARTY TRANSACTIONS (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Jul. 07, 2022	Apr. 25, 2022	Oct. 04, 2021	May 03, 2021
RELATED-PARTY TRANSACTIONS
Long-term Debt	$ 350,655	$ 170,323
Report Right, LLC
RELATED-PARTY TRANSACTIONS
Total expense incurred	509	141
Seller Note - Pre-Clinical Research Services
RELATED-PARTY TRANSACTIONS
Long-term Debt	615	685
Seller Note - Bolder BioPATH
RELATED-PARTY TRANSACTIONS
Long-term Debt	808	1,500
Total expense incurred	56
Seller Note - Plato BioPharma
RELATED-PARTY TRANSACTIONS
Long-term Debt	1,470	0
Total expense incurred	107
Seller Note - Histion
RELATED-PARTY TRANSACTIONS
Long-term Debt	369	0
Total expense incurred	7
Seller Note - Protypia
RELATED-PARTY TRANSACTIONS
Long-term Debt	600	0
Total expense incurred	4
Unsecured promissory note | Seller Note - Bolder BioPATH
RELATED-PARTY TRANSACTIONS
Principal amount						$ 1,500
Unsecured promissory note | Seller Note - Plato BioPharma
RELATED-PARTY TRANSACTIONS
Principal amount					$ 3,000
Unsecured promissory note | Seller Note - Histion
RELATED-PARTY TRANSACTIONS
Principal amount				$ 433
Unsecured promissory note | Seller Note - Protypia
RELATED-PARTY TRANSACTIONS
Principal amount			$ 600
LS Associates
RELATED-PARTY TRANSACTIONS
Consulting fees	$ 363	$ 86